Answers are grounded in this paper and cite their sources.
CRAMP was identified from a cDNA clone derived from a mouse femoral marrow cells as a member of cathelicidin-derived antimicrobial peptide. Tertiary structure of CRAMP in TFE/ H₂O (1 : 1, v/v) solution has been determined by NMR spectroscopy previously and consists of two amphipathic α-helices from Leu4 to Lys10 and from Gly16 to Leu33. These two helices are connected by a flexible region from Gly11 to Gly16. Analysis of series of fragments composed of various portion of CRAMP revealed that an 18-residue fragment with the sequence from Gly16 to Leu33 (CRAMP-18) was found to retain antibacterial activity without cytotoxicity. The effects of two Phe residues at positions 14 and 15 of CRAMP-18 on structure, antibacterial activity, and interaction with lipid membranes were investigated by Phe14,15 → Ala substitution (CRAMP-18-A) in the present study. Substitution of Phe with Ala in CRAMP-18 caused a significant reduction on antibacterial and membrane-disrupting activities. Tertiary structures of CRAMP-18 in 50% TFE/ H₂O (1 : 1, v : v) solution shows amphipathic α -helix, from Glu²\;to\;Leu¹⁸ , while CRAMP-18-A has relatively short amphipathic α -helix from Leu⁴\;to\;Ala¹⁵ . These results suggest that the hydrophobic property of Phe¹⁴\;and\;Phe¹5 in CRAMP-18 is essential for its antibacterial activity, α -helical structure, and interactions with phospholipid membranes.
No takes yet. Share an insight, caveat, or question.
Kyongsoo Park (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: